Ganoderma Tea on Eczema Patient
Product Functional Study of Effect A Master Ganoderma Detox Tea on Eczema Patient
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a single-blind, cross-over pilot study to observe the safety and efficacy of Ganoderma tea on eczema patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 18, 2015
CompletedFirst Posted
Study publicly available on registry
August 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedAugust 27, 2015
August 1, 2015
7 months
August 18, 2015
August 24, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Oriented Eczema Measure
16 weeks
Secondary Outcomes (1)
Eczema Area and Severity Index
16 weeks
Study Arms (2)
A-first intervention
EXPERIMENTALSubjects in Arm A receive Ganoderma tea (30g) daily for 8 weeks initially, followed by 8 weeks no intervention.
B-second intervention
EXPERIMENTALSubjects in Arm B receive no intervention for 8 weeks initially, followed by receiving Ganoderma tea (30g) daily for 8 weeks .
Interventions
A Master Ganoderma Detox Tea is consisted of GANODERMA, HERBA HOUTTUYNIAE, GLYCYRRHIZAE RADIX ET RHIZOMA and RUCTUS MOMORDICAE.
Eligibility Criteria
You may qualify if:
- eczema for 1 year, without other systemic illness.
You may not qualify if:
- severe systemic illness,
- oral steroid in the last month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Chinese Medicine Building
Kowloon Tong, Kowloon, 0000, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shi Ping Zhang, PhD
Hong Kong Baptist University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 18, 2015
First Posted
August 27, 2015
Study Start
August 1, 2015
Primary Completion
March 1, 2016
Study Completion
December 1, 2016
Last Updated
August 27, 2015
Record last verified: 2015-08